About MedSciNet
MedSciNet is a Healthcare company based in Stockholm (Sweden) founded in 1995, and was acquired by Omda in May 2021. It operates as a web-based software for clinical trials and medical studies is provided. Its website medscinet.com draws about 26 thousand monthly visits. MedSciNet offers products and services including Omda Research and Omda Health Intelligence. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its legal entity is Omda AS. Its competitors include Medidata, Verily, TriNetX, Signant Health and WIRB-Copernicus Group and 4 more; 7 of its 9 listed competitors have raised funding.
Company details
MedSciNet was founded in 1995 in Stockholm, Sweden, and operates within the academic medicine sector. Web applications and online database systems are designed and developed for clinical trials, quality registries, medical biobanks, and related areas. Tools such as MedSciNet Builder for creating trial applications, MedSciNet Tracker for managing multiple trials in organizations, and MedSciNet Planner for clinical trial support units are offered to researchers and institutions.
- Headquarters Stockholm, Sweden
- Stage Acquired
- SectorsHealthcare
- Website medscinet.com
- Social LinkedIn X Facebook
- Acquired by Omda (May 2021)
- Legal Name Omda As
- Latest Funding Round$131.51K (USD), Grant
Jan 2016
- InvestorsEuropean Union
& 1 more
- Acquired byOmda
(May 2021)
Products & Services of MedSciNet
MedSciNet offers a comprehensive portfolio of products and services, including Omda Research and Omda Health Intelligence.
Software for managing clinical trials and data analysis.
Tools for healthcare data insights and decision support.
Funding Insights of MedSciNet
- Total Rounds 1
- Last Round Grant — $131,508
- First Round $131,508
(Jan 2016)
- Investors Count 1
All 1 funding rounds of MedSciNet with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2016 | $131,508 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in MedSciNet
MedSciNet has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Omda.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Regulatory and security compliant software solutions are provided by Omda. | 1999 | omda.com | Oslo, Norway |
Investor details for MedSciNet
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of MedSciNet
3 dated milestones of MedSciNet across 26 years, from founding to its latest funding, stage changes and deals.
- Founded MedSciNet is founded.
- Funding First funding round of $132K.
- Exit Acquired by Omda.
Competitors of MedSciNet
MedSciNet has 9 listed competitors in our database, 7 of them funded. They include Medidata, Verily, TriNetX, Signant Health and WIRB-Copernicus Group, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| medidata.com | 1999 | New York, United States | $41.5M | 1,677 | Medidata is recognized as a leading provider of SaaS solutions for clinical research. | |
| verily.com | 2015 | Dallas, United States | $2.5B | – | AI-based solutions for health management are provided. | |
| trinetx.com | 2013 | Cambridge, United States | $53M | 95 | Clinical trial management software is provided for researchers and professionals. | |
| signanthealth.com | 2000 | Plymouth Meeting, United States | – | – | Signant Health is engaged in providing clinical trial technology solutions. | |
| wcgclinical.com | 2012 | Princeton, United States | – | 229 | Regulatory and ethical review services for clinical research are provided. | |
| deep6.ai | 2013 | Pasadena, United States | $54.79M | 41 | AI enabled solutions for clinical trials | |
| clinicalink.com | 2006 | Winston-salem, United States | $13.15M | 283 | Paperless eSource and patient engagement solutions for clinical trials | |
| massivebio.com | 2014 | New York, United States | $14.13M | – | Provider of AI-based clinical trial management tool | |
| farohealth.com | 2019 | San Diego, United States | $35M | 20 | Faro Health is focused on digital clinical trial protocol design. |
Detailed competitors of MedSciNet
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of MedSciNet
The website of MedSciNet (medscinet.com) receives about 26K visits a month.
- Monthly visits26K
▼ 9.4% vs previous month
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as MedSciNet (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about MedSciNet
MedSciNet was founded in 1995 and raised its 1st funding round 21 years after it was founded.
MedSciNet is headquartered in Stockholm, Sweden.
MedSciNet was founded in 1995 in Stockholm, Sweden, and operates within the academic medicine sector. Web applications and online database systems are designed and developed for clinical trials, quality registries, medical biobanks, and related areas. Tools such as MedSciNet Builder for creating trial applications, MedSciNet Tracker for managing multiple trials in organizations, and MedSciNet Planner for clinical trial support units are offered to researchers and institutions.
MedSciNet offers Omda Research and Omda Health Intelligence.
MedSciNet has 2 investors. Key investors include European Union, and Omda.
MedSciNet operates through Omda As.
Yes. MedSciNet was acquired by Omda in May 2021.